Shockwave Medical rises on positive quarterly results
** Shares of medical device co Shockwave Medical Inc
SWAV.O rise 6.80% to $204.25 premarket
** Co late on Thursday reported Q4 adj. earnings of $1.18
per share, ahead of analysts' estimate of $1.01 per share -
Refinitiv IBES data
** Co's revenue rose 71.1% to $144 mln, beating analysts'
estimate of $142.6 mln
** SWAV sees revenue for full-year 2023 to range from $660
mln to $680 mln
** Co stock up ~15% in 2022
(Reporting by Sriparna Roy)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on Shockwave Medical
See all newsSarepta Therapeutics gains on S&P MidCap inclusion
Brief: Sarepta Therapeutics Set To Join S&P Midcap 400
Brief: Shockwave Medical Required Waiting Period For Johnson & Johnson Merger Expired On May 20
Shockwave Medical Inc reports results for the quarter ended in January - Earnings Summary
Brief: Shockwave Medical Q1 EPS USD 1.44